Why Tekmira Pharmaceuticals (TKMR) Stock Is Surging Today

NEW YORK (TheStreet) -- Tekmira Pharmaceuticals  (TKMR) surged Thursday as takeover talks swirl around the Vancouver-based biotech company.

Daily Mail reports Tekmira is a potential takeover target for at least four drug companies, including GlaxoSmithKline  (GSK) and Shire.

Tekmira is developing treatments for the Ebola virus, which has been breaking out since it appeared in a village in Guinea in December.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The stock was up 10.38% to $21.80 at 11:11 a.m. More than 4.7 million shares had changed hands, compared to the average volume of 2,417,160.

TKMR Chart TKMR data by YCharts

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

If you liked this article you might like

3 Stocks Pushing The Drugs Industry Lower

Tekmira Pharmaceuticals (TKMR) Weak On High Volume

Tekmira Pharmaceuticals (TKMR): Today's Weak On High Volume Stock

'Mad Money' Lightning Round: Buy, Buy, Buy Yahoo!, Not Alibaba

Jim Cramer's 'Mad Money' Recap: 'Hit and Run' Investors Are the Worst